Asia-Pacific to Drive Demand for Radiopharmaceuticals as the Global Market is Projected to Reach $12 billion by 2030

The latest version of the report from Industry Experts Inc, on "Radiopharmaceuticals market," is released. According to this market research report, the global Radiopharmaceuticals market size is estimated at US$6.8 billion in 2024 and projected to post a CAGR of 10.3% between 2024 and 2030 to reach US$12.2 billion in 2030.

The radiopharmaceuticals market is witnessing significant growth, fueled by an increase in the prevalence of cancer and cardiovascular diseases, advancements in imaging technology, and a transition toward personalized medicine. These substances enable accurate diagnoses and targeted treatments, minimizing damage to healthy tissues. Support from government entities, increased investment in research and development, and favorable regulatory approvals are driving innovation and helping resolve supply chain challenges associated with short-lived radioisotopes.

North America leads the global radiopharmaceuticals market with an estimated 42.6% share in 2024, supported by a strong healthcare system, prominent pharmaceutical companies, and substantial investments in research and development. The United States is a major contributor with its advanced imaging technologies, high rates of chronic diseases, and conducive regulatory environment that promotes innovation and market expansion. Conversely, the Asia-Pacific region is expected to experience the fastest growth rate, achieving a CAGR of more than 13% during the forecast period 2024-2030, driven by the increasing incidence of chronic diseases, enhanced healthcare infrastructure, rising government expenditures, and growing awareness of nuclear medicine.

The market for radiopharmaceuticals analyzed in this report globally across all major regions including North America (The United States, Canada, and Mexico), Europe (Germany, France, the United Kingdom, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, South Korea, and Rest of Asia-Pacific) and Rest of World.

Radiopharmaceuticals report analyzes the global market trends and outlook with respect to Type – Diagnostic (SPECT Radiopharmaceuticals and PET Radiopharmaceuticals), Therapeutic (Alpha Emitters, Beta Emitters and Brachytherapy Isotopes); Radioisotope – Technetium-99m [Tc-99m], Fluorine-18 [F-18], Lutetium-177 [Lu-177], Iodine-131 [I-131], Gallium-68 [Ga-68], Yttrium-90 [Y-90] and Others [Including Radium-223 {Ra-223}, Rubidium-82, Actinium-225 {Ac-225}, Strontium-89, Copper-64, and more]; Application – Oncology, Cardiology, Neurology and Other Applications [Including Endocrinology, Bone & Skeletal Disorders, Infectious Diseases, Gastrointestinal Disorders, Rheumatologic and Rare Diseases]; and End-Use Facility – Hospitals & Clinics, Medical Imaging Centers, Other End-Users [Including Academic & Research Institutes, Specialty Clinics, Contract Research Organizations {CROs}, and Radiopharmacies].

About Industry Experts, Inc
Industry Experts, Inc., ranks among the leading market research providers globally. The company's off-the-shelf and customized business intelligence reports offer strategic insights and valuable guidance to enable various stakeholders, such as corporate strategists, analysts, researchers and startups, among others, in obtaining valuable, crisp and unbiased current and future market data. For more information, contact us on +1-320-497-3787 or visit https://industry-experts.com/

Comments

Popular posts from this blog

Demand for Europium to Reach US$373.3 million by 2030 Fostered by Phosphors and Consumer Electronic Applications

Oil & Gas Fuels Demand for Duplex Stainless Steel and Global Market to Reach $6 billion by 2030

Copper Demand to Reach US$368.8 B by 2030 Propelled by the Wide Range of Applications of the Metal Across Sectors